Altered prefrontal cortex gene expression and disrupted prepulse inhibition following neonatal NMDA receptor blockade with MK-801.

Altered prefrontal cortex gene expression and disrupted prepulse inhibition following neonatal NMDA receptor blockade with MK-801.

Bibliographische Detailangaben
Hauptverfasser:	Inkster, B, Wiseman, H, Harrison, P
Format:	Conference item
Veröffentlicht:	2003

Ähnliche Einträge

Different effects of isolation-rearing and neonatal MK-801 treatment on attentional modulations of prepulse inhibition of startle in rats
von: Wu, Z, et al.
Veröffentlicht: (2016)

Different effects of isolation-rearing and neonatal MK-801 treatment on attentional modulations of prepulse inhibition of startle in rats
von: Wu, Z, et al.
Veröffentlicht: (2016)

PSYCHOPHARMACOLOGICAL PROFILE OF THE NMDA RECEPTOR ANTAGONIST MK-801
von: Iversen, S, et al.
Veröffentlicht: (1987)

Effect of intermittent subchronic MK‐801 administration on dopamine synthesis capacity and responsiveness in the prefrontal cortex
von: Kazuro Shibata, et al.
Veröffentlicht: (2024-06-01)

Effect of Neonatal Treatment With the NMDA Receptor Antagonist, MK-801, During Different Temporal Windows of Postnatal Period in Adult Prefrontal Cortical and Hippocampal Function
von: Maria E. Plataki, et al.
Veröffentlicht: (2021-06-01)

Olanzapine Reverses MK-801-Induced Cognitive Deficits and Region-Specific Alterations of NMDA Receptor Subunits
von: Xiao Liu, et al.
Veröffentlicht: (2018-01-01)

Cell type-specific pharmacology of NMDA receptors using masked MK801
von: Yunlei Yang, et al.
Veröffentlicht: (2015-09-01)

Knockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801
von: Bygrave, A, et al.
Veröffentlicht: (2016)

Histamine H3 receptor activation reduces the impairment in prepulse inhibition (PPI) of the acoustic startle response and Akt phosphorylation induced by MK-801 (dizocilpine), antagonist at N-Methyl-d-Aspartate (NMDA) receptors
von: Aquino-Miranda, G, et al.
Veröffentlicht: (2019)

HYPOTHERMIA BUT NOT NMDA RECEPTOR ANTAGONIST MK-801 ATTENUATES NEURON DAMAGE - ARE THE RESULTS CONCLUSIVE - REPLY
von: Buchan, A, et al.
Veröffentlicht: (1992)

MK-801-exposure induces increased translation efficiency and mRNA hyperacetylation of Grin2a in the mouse prefrontal cortex
von: Liting Xue, et al.
Veröffentlicht: (2024-12-01)

The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
von: Tricklebank, MD, et al.
Veröffentlicht: (1989)

Sex-specific effects of subchronic NMDA receptor antagonist MK-801 treatment on hippocampal gamma oscillations
von: Tim Simon Neuhäusel, et al.
Veröffentlicht: (2024-08-01)

Protective effect of resveratrol on kidney and liver histopathology induced by nmda receptor antagonist mk-801 in mice
von: Murat Sırrı AKOSMAN, et al.
Veröffentlicht: (2019-08-01)

Repeated Blockade of NMDA Receptors during Adolescence Impairs Reversal Learning and Disrupts GABAergic Interneurons in Rat Medial Prefrontal Cortex
von: Jitao eLi, et al.
Veröffentlicht: (2016-03-01)

The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke.
von: Buchan, A, et al.
Veröffentlicht: (1992)

Use of Quantitative Electroencephalography to Inform Age- and Sex-Related Differences in NMDA Receptor Function Following MK-801 Administration
von: Kimberly M. Holter, et al.
Veröffentlicht: (2024-02-01)

Effect of MK-801, an antagonist of NMDA receptor in the pedunculopontine tegmental nucleus, on cardiovascular parameters in normotensive and hydralazine hypotensive rats
von: Mohammad Reza Hosseiniravesh, et al.
Veröffentlicht: (2022-05-01)

Metabolomic analysis reveals metabolic disturbance in the cortex and hippocampus of subchronic MK-801 treated rats.
von: Liya Sun, et al.
Veröffentlicht: (2013-01-01)

Non-competitive NMDA antagonist MK-801 prevents memory reconsolidation impairment caused by protein synthesis inhibitors in young chicks
von: A. A. Tiunova, et al.
Veröffentlicht: (2024-07-01)

Effects of Transient Administration of the NMDA Receptor Antagonist MK-801 in <i>Drosophila melanogaster</i> Activity, Sleep, and Negative Geotaxis
von: Thiago C. Moulin, et al.
Veröffentlicht: (2023-01-01)

A NMDA receptor antagonist, MK-801 impairs consolidating extinction of auditory conditioned fear responses in a Pavlovian model.
von: Jun-Li Liu, et al.
Veröffentlicht: (2009-01-01)

Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D3 Receptor Blockade
von: Sebastiano Alfio Torrisi, et al.
Veröffentlicht: (2017-10-01)

Correction: Acute NMDA Receptor Antagonism Disrupts Synchronization of Action Potential Firing in Rat Prefrontal Cortex
Veröffentlicht: (2014-01-01)

Correction: Acute NMDA Receptor Antagonism Disrupts Synchronization of Action Potential Firing in Rat Prefrontal Cortex.
Veröffentlicht: (2014-01-01)

Effect of MK-801 and clozapine on the proteome of cultured human oligodendrocytes
von: Juliana Silva Cassoli, et al.
Veröffentlicht: (2016-03-01)

Neuroprotectionby MK-801 following cerebral ischemia in Mongolian gerbils
von: Radenović Lidija, et al.
Veröffentlicht: (2008-01-01)

A neurodevelopmental, glutamatergic model relevant to schizophrenia? MK801-induced apoptosis in the neonatal rat produces molecular changes in the adult brain
von: Harris, L, et al.
Veröffentlicht: (2003)

NMDA receptors on parvalbumin-positive interneurons and pyramidal neurons both contribute to MK-801 induced gamma oscillatory disturbances: Complex relationships with behaviour
von: Matthew R. Hudson, et al.
Veröffentlicht: (2020-02-01)

Modulating NMDA receptors to treat MK-801-induced schizophrenic cognition deficit: effects of clozapine combining with PQQ treatment and possible mechanisms of action
von: Xingqin Zhou, et al.
Veröffentlicht: (2020-03-01)

Activation of basolateral amygdala to anterior cingulate cortex circuit alleviates MK-801 induced social and cognitive deficits of schizophrenia
von: Xin Huang, et al.
Veröffentlicht: (2022-12-01)

The competitive NMDA antagonist AP5, but not the non-competitive antagonist MK801, induces a delay-related impairment in spatial working memory in rats.
von: Tonkiss, J, et al.
Veröffentlicht: (1991)

CURCUMIN NANODELIVERY EFFECTS ON MK-801 INDUCED SCHIZOPHRENIA-LIKE BEHAVIORS
von: Marina Picó-Gallardo, et al.
Veröffentlicht: (2023-10-01)

Pharmacological Discrimination of Effects of MK801 on Thalamocortical, Mesothalamic, and Mesocortical Transmissions
von: Motohiro Okada, et al.
Veröffentlicht: (2019-11-01)

Systemic dizocilpine (MK-801) facilitates performance in opposition to response bias
von: Lauwereyns Johan, et al.
Veröffentlicht: (2007-09-01)

Effects of haloperidol inhalation on MK-801- and memantine-induced locomotion in mice
von: Hiroshi Ueno, et al.
Veröffentlicht: (2020-01-01)

Angiotensin IV Receptors in the Rat Prefrontal Cortex: Neuronal Expression and NMDA Inhibition
von: Zsolt Tamás Papp, et al.
Veröffentlicht: (2024-12-01)

Neonatal NMDA receptor blockade disrupts spike timing and glutamatergic synapses in fast spiking interneurons in a NMDA receptor hypofunction model of schizophrenia.
von: Kevin S Jones, et al.
Veröffentlicht: (2014-01-01)

Dystonia induced by combined treatment with L-dopa and MK-801 in parkinsonian monkeys.
von: Rupniak, N, et al.
Veröffentlicht: (1992)

Anxiolytic-like and antinociceptive effects of MK-801 accompanied by sedation and ataxia in primates.
von: Rupniak, N, et al.
Veröffentlicht: (1993)